Illinois Featured Content

  • High-volume antibody testing could speed disease research, treatment development

    Sep 3, 2025 4:30 pm by Liz Ahlberg TouchstoneInnovation
    Graduate student Owen Ouyang, left, and professor Nicholas Wu found common features among antibodies that bind to the influenza antigen hemagglutinin, a key target for vaccine development. Photo by Michelle Hassel

    Images

    • Graduate student Owen Ouyang, left, and professor Nicholas Wu found common features among antibodies that bind to the influenza antigen hemagglutinin, a key target for vaccine development. Photo by Michelle Hassel

    U. of I. researchers have developed a new high-volume method that can rapidly build and test large numbers of antibodies. With it, they have already uncovered common aspects of how antibodies bind across variants of a key influenza target protein.